Addo, R, Mulhern, B, Norman, R, Owusu, R, Viney, R & Nonvignon, J 2025, 'An EQ-5D-5L Value Set for Ghana Using an Adapted EuroQol Valuation Technology Protocol', Value in Health Regional Issues, vol. 45, pp. 101045-101045.
View/Download from: Publisher's site
Bahrampour, M, Kochovska, S, Currow, DC, Viney, R & Mulhern, B 2025, 'Testing the psychometric characteristics of EQ-5D-5L and respiratory bolt-ons using a sample of the Australian population', Quality of Life Research, vol. 34, no. 2, pp. 395-403.
View/Download from: Publisher's site
View description>>
Abstract Purpose The EQ-5D has been used to assess health related quality of life (HRQoL) in respiratory conditions. However, the core descriptive system may not be sensitive to all the HRQoL impacts of these conditions. To increase the sensitivity of the descriptive system, two respiratory specific bolt-ons, have been developed. Psychometric assessment of the bolt-ons in comparison to other validated instruments is required to facilitate their use. Therefore, the aim of this study is to test the psychometric characteristics of the EQ-5D-5L + R using a large dataset collected in Australia. Methods A cross-sectional online survey was used to recruit adult respondents (≥ 18 years) representative of the Australian population. Descriptive and psychometric analyses were used to understand the performance of the EQ-5D-5L and bolt-ons in comparison to other validated instruments. The construct validity was estimated using correlations. Known-group validity was tested to determine the sensitivity of the instruments to differences across different severity groups. Results Overall 10,033 respondents (52% female) completed the survey, of which 300 had a respiratory condition. There were moderate to high correlation between bolt-ons with EQ-5D-5L and WHODAS. The EQ-5D-5L + bolt-ons slightly reduced the ceiling effect in comparison to the EQ-5D-5L. The effect size was larger for people with respiratory conditions than people who did not have a respiratory condition. Conclusion The results show that adding the respiratory bolt-on to the EQ-5D-5L...
Bates, SM, Lin, J, Allen, L, Wright, M & Kidd, M 2025, 'The impact of patient enrolment in primary care on continuity and quality of care around the world, 2014–2024, and lessons for Australia: a scoping review', Medical Journal of Australia, vol. 222, no. 9, pp. 462-471.
View/Download from: Publisher's site
View description>>
AbstractObjectivesTo identify publications examining the enablers of and barriers to patient enrolment in primary care and its impact on continuity and quality of care; to assess the likely effectiveness of voluntary patient enrolment (MyMedicare) in Australia with regard to improving continuity of care and supporting other health care reforms.Study designScoping review of peer‐reviewed journal article published in English during 1 January 2014 – 12 July 2024 that evaluated primary care enrolment models, including patient enrolment enablers and barriers.Data sourcesPubMed, Cochrane Database of Systematic Reviews, Embase, CINAHL (Cumulated Index in Nursing and Allied Health Literature), PsycINFO, PAIS (Public Affairs Information Service), Web of Science, Scopus. The bibliographies of included articles were checked for further relevant publications.Data synthesisThe database searches and bibliography checks identified 508 potentially relevant articles; we reviewed the full text of 66 articles after title and abstract screening, of which 24 publications met our inclusion criteria. Twenty‐two of the included studies were undertaken in fifteen countries, including eleven in Canada, four in Australia, and two each in the United Kingdom and New Zealand; one publication compared schemes in twelve countries, one was a rapid review. The characteristics of patient enrolment models differ greatly between countries in both form and implementation, including the mandatory and voluntary components. We found little evidence that enrolment improved continuity of care. However, existing patient engagement with usual general practitioners was high among participants in many studies, and some studies involved patients wh...
Caush, L, Church, J, Goodall, S & Lord, RV 2025, 'Factors influencing the cost-effectiveness of radiofrequency ablation for Barrett’s esophagus with low-grade dysplasia in Australia', Diseases of the Esophagus, vol. 38, no. 1.
View/Download from: Publisher's site
View description>>
Abstract Endoscopic eradication therapy using radiofrequency ablation (RFA) is considered an acceptable alternative to surveillance monitoring for Barrett’s esophagus with low-grade dysplasia (LGD). This study aimed to estimate whether RFA for LGD is cost-effective and to determine which factors influence cost-effectiveness. A Markov model was developed to estimate the incremental cost per quality-adjusted life year (QALY) gained for RFA compared with endoscopic surveillance. An Australian longitudinal cohort study (PROBE-NET) provides the basis of the model. Replacing surveillance with RFA yields 10 fewer cases of HGD and 9 fewer esophageal adenocarcinoma (EAC)-related deaths per 1000 patients’ treatment, given on average 0.192 QALYs at an additional cost of AU$9211 (€5689; US$6262) per patient (incremental cost-effectiveness ratio AU$47,815 per QALY). The model is sensitive to the rate of EAC from LGD health state, the utility values, and the number of RFA sessions. Hence, the incremental benefit ranges from 0.080 QALYs to 0.198 QALYs leading to uncertainty in the cost-effectiveness estimates. When the cancerous progression rate of LGD falls <0.47% per annum, the cost-effectiveness of RFA becomes questionable. RFA treatment of LGD provides significantly better clinical outcomes than surveillance. The additional cost of RFA is acceptable if the LGD to EAC rate is >0.47% per annum and no more than three RFA treatment sessions are provided. Accurate estimates of the risk of developing EAC in patients with LGD are needed to validate the analyses.
Cunich, M, Barakat-Johnson, M, Arora, S, Church, J, Lai, M, Stephenson, J, Basjarahil, S, Campbell, JL, Disher, G, Geering, S, Ko, N, Leahy, C, Leong, T, McClure, E, O’Grady, M, Walsh, J, White, K & Coyer, F 2025, 'A Health Economic Analysis of ‘A Novel Implementation of Best Evidence Practice for Incontinence-Associated Dermatitis’ (IMBED).', Journal of Tissue Viability, pp. 100930-100930.
View/Download from: Publisher's site
Gilbert, AS, Batchelor, F, Devlin, N, Dow, B, Mulhern, B, Viney, R, Peasgood, T & Engel, L 2025, 'Routine Quality-of-Life Measurement in Residential Aged Care: Staff, Resident, and Family Perspectives', The Patient - Patient-Centered Outcomes Research, vol. 18, no. 3, pp. 211-223.
View/Download from: Publisher's site
Gofton, C, Bartolomeo, AD, Wijekulasuriya, S, Cai, S, Boutros, R, Stafford-Bell, F, Caldwell, K, McCaughan, G, Zekry, A, Strasser, SI, Levy, M, Sheehan, C, Goodall, S, Davis, JM, Sheahan, L, Liu, K, Greenaway, S, Davison, S, Huynh, TD, Quadri, Z, Zurynski, YA, Agar, M & George, J 2025, 'Palliative and supportive care in patients with hepatocellular carcinoma: a qualitative study on attitudes and perceptions of health professionals', Supportive Care in Cancer, vol. 33, no. 5.
View/Download from: Publisher's site
View description>>
Abstract Background Integration of palliative and supportive care in cancer treatment pathways is becoming standardised. While there has been significant qualitative research in oncology on palliative and supportive care integration into clinical care, there is little evidence that focusses on clinicians who manage hepatocellular carcinoma (HCC) and their perceptions on palliative and supportive care. Aim To investigate the attitudes and perceptions regarding palliative and supportive care of healthcare professionals managing patients with HCC. Design Qualitative study involving semi-structured individual interviews transcribed verbatim and analysed thematically. Setting/participants. A total of 25 healthcare professionals including hepatologists, gastroenterology trainees, hepatology clinical nurse consultants, social workers, and palliative care specialists providing care to patients with HCC recruited at 4 tertiary hospitals via purposive sampling. Results The following themes emerged: (1) availability of palliative care services, (2) need for clear referral pathways and processes, (3) patients’ limited understanding of palliative care, (4) recognition of benefits of palliative care, and (5) the lack of training in hepatology services for palliative care provision. Conclusion Health professionals’ perceptions of integration of palliative and supportive care in live...
Henderson, N, Hodgson, S, Mulhern, B, Page, K & Sampson, C 2025, 'A qualitative systematic review of the impact of hearing on quality of life', Quality of Life Research, vol. 34, no. 4, pp. 879-892.
View/Download from: Publisher's site
View description>>
Abstract Purpose Hearing loss, deafness, and other hearing-related conditions can significantly impact quality of life; numerous qualitative studies have sought to describe these impacts. Synthesis of these findings may provide additional or more robust insights. Methods A qualitative systematic review of studies reporting qualitative data relating to the impact of hearing problems on adults’ health-related quality of life. A subset of studies was included in the review and subsequently analysed using a thematic approach. Results The literature search yielded 129 studies, of which 22 met our inclusion criteria and were included for analysis. The included studies, primarily from Australia, the UK, and the USA, involved approximately 450 participants with various hearing conditions. Semi-structured interviews and focus groups were the most common data collection methods, with thematic analysis being the predominant analytical approach. Three overarching categories of descriptive themes were identified: Physical, Mental, and Social. Physical encompassed sound localization, sound clarity, speech, and physical fatigue. Social included relationships, isolation, communication, independence, work function, social stigma, and confidence. Mental encompassed depression, anxiety, listening effort, mental fatigue, fear, and identity. The identified themes shed light on the diverse domains of health-related quality of life affected by hearing conditions. Conclusion Differences in hearing function impact upon people’s health-related quality of li...
Kalisch Ellett, LM, Janetzki, JL, Lim, R, Laba, T & Pratt, NL 2025, 'Innovations in pharmacovigilance studies of medicines in older people', British Journal of Clinical Pharmacology, vol. 91, no. 1, pp. 66-83.
View/Download from: Publisher's site
View description>>
Pharmacovigilance is defined by the World Health Organization as “the science and activities relating to the detection, assessment, understanding and prevention of adverse effects or any other medicine/vaccine related problem”. Pharmacovigilance studies are critical for detecting and assessing adverse events of medicines that may not have been observed in clinical trials. This activity is especially important in older people who are often excluded from clinical trials as they have multiple chronic conditions and use multiple medicines for longer durations than the clinical trials. In this narrative review we describe innovative methods in pharmacovigilance studies of medicines in older people that leverage the increasing availability of digital health technologies, electronic health records and real‐world health data to identify and quantify medication related harms in older people.
Kuharic, M, Mulhern, B, Sharp, LK, Turpin, RS & Pickard, AS 2025, 'Delineating Care Recipient Burden Constructs: Development and Validation of the CARE-2B Scale for Care Recipient Self-Perceived Burden and Proxy Assessment of Caregiver Burden', The Gerontologist, vol. 65, no. 4.
View/Download from: Publisher's site
View description>>
Abstract Background and Objectives Care Recipient Self-Perceived Burden (CR-SPB) to Caregivers is an important but overlooked aspect within the caregiver-care recipient relationship. This study aimed to (a) develop and validate the CARE-2B (Care Recipient’s Two Burden) Scale, assessing both CR-SPB and their proxy assessment of caregiver burden (Proxy-CB); and (b) examine whether the CR-SPB and Proxy-CB differ from caregiver burden’s own assessment and other health and social care constructs. Research Design and Methods Data were collected from 504 caregiver-care recipient dyads in the United States using an online panel between August 2022 and February 2023. Care recipients completed the CARE-2B Scale, which includes two subscales: CR-SPB and Proxy-CB. Care recipients also completed measures related to health and well-being: SPB-scale, EQ-5D-5L, and EQ Health and Well-Being (EQ-HWB). Caregivers completed Care-Related Quality of Life (CarerQoL) and Adult Social Care Outcomes Toolkit for Carers (ASCOT-Carer). Psychometric analysis included exploratory and confirmatory factor analysis, item response theory (IRT), and construct validity. Results CR-SPB correlated strongly with the SPB-scale (r = 0.73), whereas Proxy-CB correlated more strongly with caregiver-reported burden (r = 0.61). Both CR-SPB and Proxy-CB items demonstrated good discrimination and information coverage in IRT analysis. Exploratory factor analysis further supported the distinctiveness of CR-SPB and Proxy-CB, with CR-SPB items loading on a separate factor from caregiver burden and health constructs, whereas Proxy-...
Lin, J, Bates, S, Allen, LN, Wright, M, Mao, L, Chomik, R, Dietz, C & Kidd, M 2025, 'Uptake of patient enrolment in primary care and associated factors: a systematic review and meta-analysis', BMC Primary Care, vol. 26, no. 1, p. 76.
View/Download from: Publisher's site
View description>>
BACKGROUND: Patient enrolment in primary care refers to the formal process of registering patients with a specific primary care provider, team, or practice. This approach is often expected to enhance continuity and coordination of care. However, limited information exists on the uptake of patient enrolment and its associated characteristics. This review aimed to estimate the uptake of patient enrolment in primary care and examine factors associated with decisions around enrolment. METHODS: Eight electronic databases (PubMed, Cochrane Register of Systematic Reviews, Embase, CINAHL, PsycINFO, PAIS, Web of Science, and Scopus) were searched for peer-reviewed articles published from January 2014 to July 2024. Findings from included studies were extracted and synthesised, with uptake estimated through meta-analysis and factors associated with enrolment summarised narratively. REVIEW REGISTRATION: PROSPERO CRD42024597078. RESULTS: Ten studies across nine publications were included. Of these, eight studies with 27,919,216 participants were included in the meta-analysis. The results showed a pooled patient enrolment uptake rate of 71.4% (95% Confidence Interval [CI]: 13.6-97.5%). There was no significant difference in enrolment rates between population-wide and program-based enrolment (72.4% vs. 73.5%; p = 0.980). Several associated factors were identified in three publications. Women showed higher enrolment rates than men (adjusted odds ratio [aOR] = 1.07, 95% CI: 1.07-1.08), while recently arrived immigrants in a country had lower enrolment rates than the established population (aOR = 0.40, 95% CI: 0.40-0.41). Patients living in small urban/suburban/rural areas had higher enrolment rates than those in large urban/metropolitan regions (aORs: 1.17-2.18). Higher socioeconomic level was associated with increased rates of enrolment. Patients with some specific chronic health conditions, such as those with diagnosed mental illness or substance use disorders, had lo...
Manipis, K, Cronin, P, Street, D, Church, J, Viney, R & Goodall, S 2025, 'Examination of Methods to Estimate Productivity Losses in an Economic Evaluation: Using Foodborne Illness as a Case Study', PharmacoEconomics, vol. 43, no. 4, pp. 453-467.
View/Download from: Publisher's site
Mazza, D, Assifi, AR, McGeechan, K, Haas, M, Peipert, JF, Lucke, J, Taft, A, McNamee, K & Black, KI 2025, 'Increasing the uptake of long-acting reversible contraception through family practice: the Australian Contraceptive ChOice pRoject (ACCORd) cluster randomized controlled trial 3-year follow-up', American Journal of Obstetrics and Gynecology.
View/Download from: Publisher's site
View description>>
BACKGROUND: Increased use of long-acting reversible contraception (LARC) can reduce the rate of unintended pregnancies and abortions. OBJECTIVE: To assess whether the Australian Contraceptive ChOice pRoject (ACCORd) trial intervention resulted in sustained LARC use and decreasing unplanned pregnancies. STUDY DESIGN: Longitudinal 3-year follow-up study of the ACCORd cluster randomised controlled trial. Study setting was metropolitan Melbourne, Australia. Participants were patients of ACCORd family physicians, identified their gender as women, and that had not actively withdrawn from the ACCORd trial 12-month survey. Intervention family physicians undertook online training to deliver structured contraceptive counselling (non-biased, scripted descriptions of all available contraceptive methods, with a particular focus on the efficacy and safety of each method) and were also given access to an online booking system enabling rapid referral to long-acting reversible contraception insertion clinics. Family physicians in the control group provided usual care. Women who participated in the original ACCORd trial were invited to take part in a follow-up survey three years after completing their original baseline assessment. The primary outcome was the continuation rate of use of long-acting reversible contraception methods compared with non-long-acting reversible contraception methods. Secondary outcomes included contraceptive method used, satisfaction with contraceptive choice, and the number of unintended pregnancies and abortions. RESULTS: 75% of the original ACCORd trial participants (N=531) agreed to take part in the follow-up study. At three years, the continuation rate of long-acting reversible contraception was 66%, significantly higher than for non-long-acting reversible contraception methods at 55% (P=0.027). Satisfaction with their method of contraception was higher among long-acting reversible contraception users compared to oral contraceptive pill use...
Naghsh-Nejad, M, Van Gool, K, Haywood, P & Hall, J 2025, 'Medicare austerity reforms and patient out-of-pocket costs: The experience from Australian cancer patients', Health Policy, vol. 155, pp. 105296-105296.
View/Download from: Publisher's site
Ng, C, Roydhouse, J, Luckett, T, Lourenco, RDA & Mulhern, B 2025, 'Using patient‐reported outcome measures in clinical trials: perspectives for and against a modular approach', Medical Journal of Australia, vol. 222, no. 7, pp. 327-330.
View/Download from: Publisher's site
Ng, C-A, Mulhern, B, Akanksha, A, Bahrampour, M, Jansons, P, Mesinovic, J, Gandham, A, Glavas, C, Ebeling, PR, Viney, R & Scott, D 2025, 'Exploring the Validity of Measures of Health-Related Quality of Life in Older Adults at Increased Risk of Falls and/or Fractures in Exercise Clinical Trials', Journal of Applied Gerontology.
View/Download from: Publisher's site
View description>>
Exercise targeting physical function and body composition may mitigate falls and fracture risk among older adults. This study aimed to identify the most valid instrument(s) to assess quality of life (QoL) in this context by comparing the psychometric properties of the EQ-5D-3L, EQ-5D-5L, CDC Healthy Days measure, Modified Falls Efficacy Scale (MFES), and Work Productivity and Activity Impairment Questionnaire. Data from four exercise trials ( n = 210, mean age 64.8 ± 7.4, 79.0% female) were analyzed. Construct validity and responsiveness were compared. There was moderate to strong convergence between the EQ-5D (-3L and -5L) and MFES, and EQ-5D-3L and CDC index (correlation: 0.45–0.61). Only the EQ-5D-3L demonstrated good known-group validity (effect size: 0.98–3.7). Responsiveness was low across all instruments (standardized response mean: −0.33–0.49). The instruments are valid for assessing QoL in older adults at risk of falls and/or fractures. However, variation in their psychometric properties should be considered when selecting instruments for exercise trials.
Page, K, Hossain, L, Liu, D, Kim, YH, Wilmot, K, Kenny, P, Campbell, M, Cumming, T, Kelly, S, Longden, T, van Gool, K & Viney, R 2025, 'Outcomes from the Victorian Healthy Homes Program: a randomised control trial of home energy upgrades', BMJ Open, vol. 15, no. 2, pp. e082340-e082340.
View/Download from: Publisher's site
View description>>
ObjectivesThe Victorian Healthy Homes Program investigated the impact of thermal home upgrades on energy and health outcomes in vulnerable, older individuals over winter in Victoria, Australia.DesignA staggered parallel-group randomised control trial design of 984 (764 per protocol (PP)) vulnerable households and 1313 (1015 PP) individuals. The intervention group received their upgrade prior to their winter of recruitment, and the control group received their upgrade after the winter of their recruitment.SettingWestern Melbourne (metropolitan) and the Goulburn Valley (regional) in Victoria, Australia.Participants1000 households were recruited: 800 from western Melbourne (metropolitan) and 200 from the Goulburn Valley (regional).InterventionA thermal comfort and home energy efficiency upgrade of up to $AUD3500 per household.Primary and secondary outcome measuresThe primary outcome was the change in indoor temperature over winter and the secondary outcomes were changes in quality of life, healthcare use and costs, self-reported health measures, energy use and costs and humidity.ResultsA relatively low-cost and simple home upgrade (average cost $A2809) resulted in reduced gas consumption (−25.5 MJ/day) and increased indoor winter temperatures (average daily increase of 0.33°C), and a reduction of exposure to cold conditions (<18°C) by an average of 0.71 hours (43 min) per day. The intervention group experienced improved mental health as measured by the short-form 36 mental component summary and social care related quality of life measured b...
Pain, T, Brown, A, Kingston, G, Perks, S, Patterson, C, Firth, N, Lester, J, Sherwood, L, Brennan, S & Street, D 2025, 'Using Best–Worst Scaling Survey to Investigate the Relative Importance of Attributes Associated with Public Hospital Outpatient Appointments', The Patient - Patient-Centered Outcomes Research, vol. 18, no. 3, pp. 237-247.
View/Download from: Publisher's site
View description>>
Abstract Introduction Obtaining patient input before healthcare redesign improves patient experience. The Townsville Hospital and Health Service, a regional Australian public health service, seeks to reduce the long wait list for medical specialist appointments by introducing allied health substitution models of care for low-acuity patients. This paper describes a best worst scaling survey conducted to refine attributes associated with outpatient appointments which will be used in a future discrete choice experiment (DCE). Methods A literature review was conducted to identify attributes associated with medical specialist outpatient appointments and allied health substitution models. An object (or case 1) best worst scaling (BWS) survey was designed using blocks of a balanced incomplete block design and analysed using multinomial logit and mixed logit models. Patients waiting at local specialist outpatient clinics were invited to complete the survey via an iPad. The interviewer collected field notes, which were analysed using content analysis. Results A total of 12 attributes were identified in the literature review and one from local discussion. The 167 completed responses demonstrated the ranking of attributes were diagnostic accuracy, symptom relief, continuity of care, satisfaction with care, healthcare professional, manner and communication, time on waitlist and onward referral. The least important attributes were reassurance offered, appointment wait time, cost and appointment duration. Conclusions This BWS survey allows us to...
Schadewaldt, V, O’Brien, T, Kalla, M, Krishnasamy, M, Burns, K, Bray, SCE, Gilbert, C, De Abreu Lourenco, R, Thomas, J, Capurro, D, Chapman, W, Borda, A, Dhillon, RS, Whittle, JR & Drummond, KJ 2025, 'Development of an evidence-informed implementation strategy for a digital supportive care platform for brain tumour patients, their carers and healthcare professionals', DIGITAL HEALTH, vol. 11.
View/Download from: Publisher's site
View description>>
Background Implementation challenges of digital health solutions (DHSs) comprise complexities of behavioural change, resource limitation, inertia in existing systems, and failure to include consumer preferences. Understanding the factors which contribute to successful implementation of DHS is essential. We report the development of an implementation strategy for Brain Tumours Online (BT Online), a digital supportive care platform for patients with brain tumours, their carers and healthcare professionals. Aim To develop an evidence-informed implementation strategy for BT Online, considering the specific barriers and facilitators to implementing DHS for adults with a brain tumour and their carers and healthcare professionals. Methods A rapid review methodology was used to summarise factors relevant to implementation of DHS for people affected by cancer. Themes from the review were supported by implementation guidelines for DHS and the combined evidence informed the implementation strategy. Each theme was matched with specific steps for implementing BT Online. Results The rapid review identified 10 themes, namely, awareness of the new digital platform; institutional integration and support; data security, the quality, usability and accessibility of the platform; belief in the benefit of the platform; the need for holistic and tailored features; the timing of introducing the platform; engagement of healthcare professionals; and the re-definition of roles and workload. The themes were matched with 51 concrete implementation steps. Discussion The purpose of the strategy was to minimise risk of implementation failure, consider the specific context of care and generate a ...
Shiroiwa, T, Yamamoto, Y, Murata, T, Mulhern, B, Bjorner, J, Brazier, J, Fukuda, T, Rowen, D & Fukuhara, S-I 2025, 'Valuation survey for SF-6Dv2 in Japan based on the international protocol', Quality of Life Research, vol. 34, no. 2, pp. 445-455.
View/Download from: Publisher's site
Taylor, N, Mazariego, C, Baffsky, R, Liang, S, Wolfenden, L, Presseau, J, Fontaine, G, Carland, JE, Shiner, CT, Wise, S, Debono, D, McKay, S, Best, S & Morrow, A 2025, 'Advancing the Speed and Science of Implementation Using Mixed-Methods Process Mapping – Best Practice Recommendations', International Journal of Qualitative Methods, vol. 24.
View/Download from: Publisher's site
View description>>
Mixed-methods process mapping is a visualisation tool that identifies the steps, resources and personnel required to deliver a clinical practice, and has been previously used in an ad hoc manner to develop effective implementation strategies and solutions. To realise the potential of mixed-methods process mapping as an implementation tool, we aimed to develop and formalize the methodological steps and provide guidance for contemporary best practice approaches to using this approach for optimising implementation practice and research. Synthesising theory, evidence and expertise, we have identified 10 best practice recommendations and provide the first systematic framework for integrating mixed-methods process mapping into three core phases of health systems implementation, specifically: (1) engaging interest holders (and maintaining engagement), (2) identifying when, where, why, and to whom change is needed (and potential consequences), and, (3) identifying barriers and enablers, and co-designing implementation strategies. For each phase, we provide: (a) a rationale for using mixed-methods process mapping, (b) best practice guidance for combining mixed-methods process mapping with implementation practice and research, and (c) case studies exemplifying best practice. This article provides intelligence on mixed-methods process mapping to improve the consistency and quality of its use among implementation researchers and practitioners. We present a rationale, guidance, and practical tools for conducting mixed-methods process mapping to enhance the quality of implementation research and practice which can be used and adapted internationally. In doing so, it builds capacity and provides an opportunity for researchers and healthcare professionals to better understand and embed evidence-based innovations into health systems, improving service and client outcomes. Further research is needed to establish potential uses of mixed-methods process mapping to ...
Thai, T, Engel, L, Ride, J, Mulhern, B, Norman, R & Mihalopoulos, C 2025, 'Developing an Australian Value Set for the Recovering Quality of Life-Utility Index Instrument Using Discrete Choice Experiment With Duration', Value in Health, vol. 28, no. 3, pp. 460-469.
View/Download from: Publisher's site
van Mossel, S, de Feria Cardet, RE, de Geus-Oei, L-F, Vriens, D, Koffijberg, H & Saing, S 2025, 'A Systematic Literature Review of Modelling Approaches to Evaluate the Cost Effectiveness of PET/CT for Therapy Response Monitoring in Oncology', PharmacoEconomics, vol. 43, no. 2, pp. 133-151.
View/Download from: Publisher's site
van Mossel, S, Oude-Wolcherink, MJ, de Feria Cardet, RE, de Geus-Oei, L-F, Vriens, D, Koffijberg, H & Saing, S 2025, 'Artificial Intelligence as a New Research Ally? Performing AI-Assisted Systematic Literature Reviews in Health Economics', PharmacoEconomics, vol. 43, no. 6, pp. 647-650.
View/Download from: Publisher's site
Vargas, C, De Abreu Lourenco, R, Espinoza, M & Goodall, S 2025, 'Correction: Systematic Literature Review of Access Pathways to Drugs for Patients with Rare Diseases', Applied Health Economics and Health Policy, vol. 23, no. 4, pp. 751-751.
View/Download from: Publisher's site
Vargas, C, De Abreu Lourenco, R, Espinoza, M & Goodall, S 2025, 'Systematic Literature Review of Access Pathways to Drugs for Patients with Rare Diseases', Applied Health Economics and Health Policy, vol. 23, no. 2, pp. 209-229.
View/Download from: Publisher's site
Wright, M & Chin, M 2025, 'Is the term bulk‐billing still relevant in today's landscape of health policy reform?', Medical Journal of Australia, vol. 222, no. 2, pp. 66-68.
View/Download from: Publisher's site
Wright, M, Bates, S, Bazemore, AW & Kidd, MR 2025, 'Evaluating primary care expenditure in Australia: the Primary Care Spend (PC Spend) model', Medical Journal of Australia, vol. 222, no. 3, pp. 149-154.
View/Download from: Publisher's site
View description>>
AbstractObjectivesTo assess the distribution of health care expenditure (public and private) for primary care and primary health care as proportions of overall health care funding.Study designThe Primary Care Spend model; estimated distribution of expenditure for three tiers of primary care services by provider and function.SettingPrimary Care Spend model applied to Australian health expenditure, public and private, 2020–21, from a health sector perspective, as recorded by the Australian Institute of Health and Welfare.Main outcome measuresProportions of all health care spending for essential community and primary health care functions (tier A), comprehensive primary care (services delivered in general practices and family physician clinics; tier B), and enhanced primary care services (long‐term holistic patient care; tier C).ResultsIn 2020–21, 33.2% of health spending in Australia was classified as primary health care spending (tier A), 6.0% as comprehensive primary care services (tier B), and 0.8% as long term holistic patient care services (tier C).ConclusionsThe application of the Primary Care Spend model to Australian data provides a more nuanced analysis of expenditure for primary health care than routine health expenditure reports. Its output could be used to inform targets for spending on different tiers, types, and locations of primary care, especially comprehensive and other high value primary care services, and to monitor progress toward these targets.
Yap, ML, Bhoo-Pathy, N, Essue, BM, Naghsh-Nejad, M, Batumalai, V, Chukwu, OA, Dowe, K, Moodley, J, Spence, D & Stanaway, FF 2025, 'Invisible Populations: The Need for Race and Ethnicity Data in Cancer Control', JCO Global Oncology, no. 11.
View/Download from: Publisher's site
Yu, S, Lui, K, Fiebig, DG, Travadi, J, Homer, CSE, Sinclair, L, Scarf, V & Viney, R 2025, 'The impact of neonatal care on moderate-risk infants: Evidence from healthcare use in the first two years of life', Journal of Health Economics, vol. 102, pp. 102995-102995.
View/Download from: Publisher's site
